Blood bank reagents
Ended Awarded Last action
- Contract number
- 36C25723N0142
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $7,634
Award facts
- Contract value 100% obligated
- $7,634.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dallas, TX 75216, USA
Award details come from SAM.gov/FPDS.
About this award
Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., was awarded a task order valued at $7,634.01 under a Blanket Purchase Agreement with Veterans Integrated Service Network 17 on May 1, 2023. This Firm Fixed Price contract, issued without set-aside designation, procures blood bank reagents through the General Services Administration Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The task order is set to complete by April 30, 2024, with performance to be delivered in Dallas, Texas. Alba Bioscience specializes in providing critical immunohematology and blood banking materials to federal healthcare systems, including monoclonal antibodies, antibody identification and screening panels, quality control kits, and specialized cell reagents essential for transfusion services.
This contract call represents routine procurement activity under Alba Bioscience's larger Blanket Purchase Agreements with the Department of Veterans Affairs, which enable VA medical facilities across multiple Veterans Integrated Service Networks to efficiently order blood banking supplies through streamlined task order processes. The vendor has established itself as a primary federal supplier of specialized blood banking diagnostics, competing successfully in the marketplace without reliance on small business set-asides, reflecting the specialized nature of its product portfolio. The Department of Veterans Affairs utilizes these procurement vehicles to ensure adequate supply of critical transfusion and diagnostic testing materials across its integrated healthcare system nationwide.
Quick answers
Who was awarded contract 36C25723N0142?
36C25723N0142 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on May 1, 2023.
How much is contract 36C25723N0142 worth?
The government has obligated $7,634 on 36C25723N0142.
Is contract 36C25723N0142 an order under another contract?
Yes. 36C25723N0142 is a BPA call under 36F79721D0259-36C25722A0011, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25723N0142 competed?
The extent of competition for 36C25723N0142 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award